ABT-101

ABT-101 · Anbogen Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABT-101, covering 2024-06-24 to 2024-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients [Phase 1, Phase 2]